{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T19:28:44Z","timestamp":1784834924984,"version":"3.55.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.drugalcdep.2020.108248","type":"journal-article","created":{"date-parts":[[2020,8,27]],"date-time":"2020-08-27T11:26:12Z","timestamp":1598527572000},"page":"108248","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"special_numbering":"C","title":["The Association between Opioid Discontinuation and Heroin Use: A Nested Case-Control Study"],"prefix":"10.1016","volume":"217","author":[{"given":"Ingrid A.","family":"Binswanger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason M.","family":"Glanz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Faul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo Ann","family":"Shoup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LeeAnn M.","family":"Quintana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Lyden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Komal J.","family":"Narwaney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2020.108248_bib0005","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.mayocp.2015.04.003","article-title":"Tapering long-term opioid therapy in chronic noncancer pain: evidence and recommendations for everyday practice","volume":"90","author":"Berna","year":"2015","journal-title":"Mayo. Clin. Proc."},{"key":"10.1016\/j.drugalcdep.2020.108248_bib0010","doi-asserted-by":"crossref","first-page":"367","DOI":"10.7326\/M18-1243","article-title":"Opioid prescribing in the United States before and after the Centers for Disease Control and Prevention\u2019s 2016 opioid guideline","volume":"169","author":"Bohnert","year":"2018","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.drugalcdep.2020.108248_bib0015","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1093\/oxfordjournals.aje.a114174","article-title":"Estimating the population attributable risk for multiple risk factors using case-control data","volume":"122","author":"Bruzzi","year":"1985","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.drugalcdep.2020.108248_bib0020","first-page":"1487","article-title":"Vital signs: overdoses of prescription opioid pain relievers---United States, 1999--2008","volume":"60","author":"Centers for Disease Control and Prevention","year":"2011","journal-title":"MMWR. Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.drugalcdep.2020.108248_bib0025","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.drugpo.2017.06.010","article-title":"Fentanyl in the US heroin supply: a rapidly changing risk environment","volume":"46","author":"Ciccarone","year":"2017","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.drugalcdep.2020.108248_bib0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0232538","article-title":"Illicit opioid use following changes in opioids prescribed for chronic non-cancer pain","volume":"15","author":"Coffin","year":"2020","journal-title":"PloS One"},{"key":"10.1016\/j.drugalcdep.2020.108248_bib0035","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jpain.2012.01.001","article-title":"Hyperalgesia in heroin dependent patients and the effects of opioid substitution therapy","volume":"13","author":"Compton","year":"2012","journal-title":"J. Pain"},{"key":"10.1016\/j.drugalcdep.2020.108248_bib0040","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1111\/j.1526-4637.2010.00937.x","article-title":"Longitudinal treatment outcomes for geriatric patients with chronic non-cancer pain at an interdisciplinary pain rehabilitation program","volume":"11","author":"Darchuk","year":"2010","journal-title":"Pain Med."},{"key":"10.1016\/j.drugalcdep.2020.108248_bib0045","doi-asserted-by":"crossref","first-page":"182","DOI":"10.2105\/AJPH.2017.304187","article-title":"Opioid crisis: no easy fix to its social and economic determinants","volume":"108","author":"Dasgupta","year":"2018","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.drugalcdep.2020.108248_bib0050","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/0895-4356(92)90133-8","article-title":"Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases","volume":"45","author":"Deyo","year":"1992","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.drugalcdep.2020.108248_bib0055","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1056\/NEJMp1904190","article-title":"No shortcuts to safer opioid prescribing","volume":"380","author":"Dowell","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drugalcdep.2020.108248_bib0060","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1001\/jama.2016.1464","article-title":"CDC guideline for prescribing opioids for chronic pain\u2014United States, 2016","volume":"315","author":"Dowell","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.drugalcdep.2020.108248_bib0065","series-title":"National Heroin Threat Assessment Summary-Updated","author":"Drug Enforcement Administration","year":"2016"},{"key":"10.1016\/j.drugalcdep.2020.108248_bib0070","doi-asserted-by":"crossref","first-page":"85","DOI":"10.7326\/0003-4819-152-2-201001190-00006","article-title":"Opioid prescriptions for chronic pain and overdose: a cohort study","volume":"152","author":"Dunn","year":"2010","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.drugalcdep.2020.108248_bib0075","first-page":"CD010323","article-title":"Interventions for the reduction of prescribed opioid use in chronic non\u2010cancer pain","volume":"11","author":"Eccleston","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.drugalcdep.2020.108248_bib0080","doi-asserted-by":"crossref","first-page":"181","DOI":"10.7326\/M17-0598","article-title":"Patient outcomes in dose reduction or discontinuation of long-term opioid therapy: a systematic review","volume":"167","author":"Frank","year":"2017","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.drugalcdep.2020.108248_bib0085","doi-asserted-by":"crossref","first-page":"837","DOI":"10.15585\/mmwr.mm6533a2","article-title":"Fentanyl law enforcement submissions and increases in synthetic opioid\u2013involved overdose deaths\u201427 states, 2013\u20132014","volume":"65","author":"Gladden","year":"2016","journal-title":"MMWR. Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.drugalcdep.2020.108248_bib0090","doi-asserted-by":"crossref","first-page":"e192613","DOI":"10.1001\/jamanetworkopen.2019.2613","article-title":"Association between opioid dose variability and opioid overdose among adults prescribed long-term opioid therapy","volume":"2","author":"Glanz","year":"2019","journal-title":"JAMA Netw. Open."},{"key":"10.1016\/j.drugalcdep.2020.108248_bib0095","article-title":"Drug overdose deaths in the United States, 1999-2018, NCHS Data Brief","author":"Hedegaard","year":"2020","journal-title":"National Center for Health Statistics, Hyattsville, MD"},{"key":"10.1016\/j.drugalcdep.2020.108248_bib0100","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1007\/s11606-019-05301-2","article-title":"Mortality after discontinuation of primary care\u2013based chronic opioid therapy for pain: a retrospective cohort study","volume":"34","author":"James","year":"2019","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/j.drugalcdep.2020.108248_bib0105","first-page":"719","article-title":"Vital signs: demographic and substance use trends among heroin users\u2014United States, 2002\u20132013","volume":"64","author":"Jones","year":"2015","journal-title":"MMWR. Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.drugalcdep.2020.108248_bib0110","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1093\/pm\/pny307","article-title":"Challenges with implementing the Centers for Disease Control and Prevention opioid guideline: a consensus panel report","volume":"20","author":"Kroenke","year":"2019","journal-title":"Pain Med."},{"key":"10.1016\/j.drugalcdep.2020.108248_bib0115","first-page":"35","article-title":"Risk set sampling in epidemiologic cohort studies","author":"Langholz","year":"1996","journal-title":"Stat. Sci."},{"key":"10.1016\/j.drugalcdep.2020.108248_bib0120","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1007\/s11606-011-1771-0","article-title":"Long-term chronic opioid therapy discontinuation rates from the TROUP study","volume":"26","author":"Martin","year":"2011","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/j.drugalcdep.2020.108248_bib0125","series-title":"Pain Management for People with Serious Illness in the Context of the Opioid Use Disorder Epidemic: Proceedings of a Workshop","author":"National Academies of Sciences Engineering and Medicine","year":"2019"},{"key":"10.1016\/j.drugalcdep.2020.108248_bib0130","first-page":"368","article-title":"Associations between stopping prescriptions for opioids, length of opioid treatment, and overdose or suicide deaths in US veterans: observational evaluation","author":"Oliva","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.drugalcdep.2020.108248_bib0135","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","article-title":"Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data","author":"Quan","year":"2005","journal-title":"Med. Care."},{"key":"10.1016\/j.drugalcdep.2020.108248_bib0140","article-title":"Consensus recommendations for national and state poisoning surveillance","author":"Safe States Aliance","year":"2012","journal-title":"The Safe States Atlanta Injury Surveillance Workgroup 7, Atlanta, GA"},{"key":"10.1016\/j.drugalcdep.2020.108248_bib0145","doi-asserted-by":"crossref","first-page":"k2990","DOI":"10.1136\/bmj.k2990","article-title":"What interventions are effective to taper opioids in patients with chronic pain?","volume":"362","author":"Sandhu","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.drugalcdep.2020.108248_bib0150","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.jpain.2016.11.003","article-title":"Prescription opioid taper support for outpatients with chronic pain: a randomized controlled trial","volume":"18","author":"Sullivan","year":"2017","journal-title":"J. Pain"},{"key":"10.1016\/j.drugalcdep.2020.108248_bib0155","article-title":"Strategy to combat opioid abuse","author":"US Department of Health and Human Services","year":"2018","journal-title":"misuse and overdose."},{"key":"10.1016\/j.drugalcdep.2020.108248_bib0160","series-title":"FDA identifies harm reported from sudden discontinuation of opioid pain medicines and requires label changes to guide prescribers on gradual, individualized tapering","author":"US Food and Drug Administration","year":"2019"},{"key":"10.1016\/j.drugalcdep.2020.108248_bib0165","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1016\/j.pain.2014.09.034","article-title":"National study of discontinuation of long-term opioid therapy among veterans","volume":"155","author":"Vanderlip","year":"2014","journal-title":"Pain"},{"key":"10.1016\/j.drugalcdep.2020.108248_bib0170","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/AJP.0b013e318169d03b","article-title":"Defacto long-term opioid therapy for non-cancer pain","volume":"24","author":"von Korff","year":"2008","journal-title":"Clin. J. Pain"},{"key":"10.1016\/j.drugalcdep.2020.108248_bib0175","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1093\/oxfordjournals.aje.a116398","article-title":"Selection of controls in case-control studies: III. Design options","volume":"135","author":"Wacholder","year":"1992","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.drugalcdep.2020.108248_bib0180","doi-asserted-by":"crossref","first-page":"e152","DOI":"10.4088\/JCP.15m10062","article-title":"Cigarette smoking is associated with increased risk of substance use disorder relapse: a nationally representative, prospective longitudinal investigation","volume":"78","author":"Weinberger","year":"2017","journal-title":"J. Clin. Psychiatry"}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871620304130?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871620304130?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T09:06:57Z","timestamp":1759828017000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871620304130"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":36,"alternative-id":["S0376871620304130"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2020.108248","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Association between Opioid Discontinuation and Heroin Use: A Nested Case-Control Study","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2020.108248","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108248"}}